- Lobbying
- Andrew AND McKechnie
Lobbying Arrangements Results for 'Andrew Mc Kechnie'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education, H.R. 2389/S. 1302 - Resident Physician Short... |
The Ickes and Enright Group (on behalf of Greater New York Hospital Association)
|
Tiber Creek Group | |||
Details Issues related to drug pricing and reimbursement for prescription drugs, Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). Issues relating to drug pricing; Issue... |
Tiber Creek Health Strategies, Inc. (on behalf of Eli Lilly and Company)
|
Tiber Creek Group | |||
Details Monitored issues related to technological solutions promoting sustainability; energy efficiency; best manufacturing practices; S. 1029; e-KNOW Act; S.1000, Energy Savings and Industrial Competitive... |
Bay Bridge Strategies (on behalf of OSIsoft)
|
Peck Madigan Jones | |||
Details General issues related to cybersecurity, general IoT issues, general data breach issues, identity issues related to data breach, general election security issues, general digital identity issues, g... |
ACCENTURE
|
Peck Madigan Jones | |||
Details Discussion of app-based technological advancements specific to economic and entrepreneurial opportunities, including the deployment of self-driving vehicles for commercial purposes; Issues related ... |
Uber Technologies, Inc.
|
Tiber Creek Group | |||
Details Issues related to the FDA and Health and Human Services pertaining to CBD policies. Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and... |
Jazz Pharmaceuticals (fka Greenwich Biosciences, Inc.)
|
Tiber Creek Group | |||
Details Issues related to government funding. H.R.2670/S.2226 - National Defense Authorization Act for Fiscal Year 2024. |
DELOITTE LLP
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B... |
PHRMA
|
Tiber Creek Group | |||
Details Issues related to antimicrobial resistance. H.R. 2940/S. 1355 - The PASTEUR Act. Issues related to the importation of non-human primates. |
Biotechnology Innovation Organization (BIO)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); S. 476 - Maintaining Investments in New Innovation Act. Is... |
Tiber Creek Health Strategies, Inc. (On behalf of Novartis)
|
Tiber Creek Group | |||
Details H.R. 133/PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act; PL 117-2 - American Rescue Plan. H.R. 6395 - FY21 National Defense Authorization Act. |
NIC Inc.
|
Tiber Creek Group | |||
Details Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to H.R. 7839 Continuing Access to In Home IVIG Act.... |
Cigna Corporation
|
Tiber Creek | |||
Details Issues impacting hospital and physician reimbursement. FEMA reimbursement issues related to hospitals and the federal COVID response; Provider reimbursement and workforce issues. |
The Ickes & Enright Group (Northwell Health fka North Shore-LIJ)
|
Tiber Creek Group |